CLDN16 and Hypercalciuria: To confirm the diagnosis of FHHNC, the triad of clinical symptoms, namely, hypomagnesemia, hypercalciuria, and renal calcifications, must be present, followed by genetic testing to identify pathogenic mutations in the CLDN16 or CLDN19 genes.